VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 128 filers reported holding VERVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,018,770 | -26.5% | 3,998,399 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $72,125,681 | +41.0% | 3,846,703 | +8.5% | 0.00% | 0.0% |
| Q1 2023 | $51,140,313 | -26.5% | 3,546,485 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $69,545,333 | -40.0% | 3,594,074 | +6.5% | 0.00% | -50.0% |
| Q3 2022 | $115,973,000 | +193.7% | 3,376,210 | +30.7% | 0.00% | +300.0% |
| Q2 2022 | $39,486,000 | -19.8% | 2,584,071 | +19.7% | 0.00% | 0.0% |
| Q1 2022 | $49,259,000 | +7.4% | 2,158,562 | +73.6% | 0.00% | 0.0% |
| Q4 2021 | $45,848,000 | +3.3% | 1,243,472 | +31.7% | 0.00% | 0.0% |
| Q3 2021 | $44,390,000 | +39.0% | 944,457 | +78.2% | 0.00% | 0.0% |
| Q2 2021 | $31,928,000 | – | 529,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
| Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
| Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
| MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
| Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
| ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
| Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
| Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
| Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
| Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |